Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence.
Signoriello E, Lus G, Saccà F, Puthenparampil M, Coppola C, Di Pietro A, Puoti G, Criscuolo MC, Foschi M, Miele G, Abbadessa G, Brescia Morra V, Gallo P, Bonavita S, Sormani MP, Signori A.
Signoriello E, et al. Among authors: signori a.
J Clin Med. 2023 Feb 22;12(5):1768. doi: 10.3390/jcm12051768.
J Clin Med. 2023.
PMID: 36902555
Free PMC article.